Overview
- Editors:
-
-
Patricia A. Broderick
-
Department of Physiology and Pharmacology, City University of New York Medical School, New York
Department of Neurology, New York University School of Medicine, New York
NYU Comprehensive Epilepsy Center, New York
-
David N. Rahni
-
Department of Chemistry and Physical Sciences, Pace University, Pleasantville
-
Edwin H. Kolodny
-
Department of Neurology, New York University School of Medicine, New York
Access this book
Other ways to access
Table of contents (23 chapters)
-
-
Parkinson’s Disease
-
-
-
-
- André R. Troiano, A. Jon Stoessl
Pages 25-35
-
- Hubert H. Fernandez, Paula D. Ravin, Dylan P. Wint
Pages 37-44
-
- Yilong Ma, Vijay Dhawan, Curt Freed, Stanley Fahn, David Eidelberg
Pages 45-57
-
Alzheimer’s Disease
-
-
-
- Jan Versijpt, Rudi A. Dierckx, Jakob Korf
Pages 75-83
-
- Ladislav Volicer, Monika Z. Wrona, Wayne Matson, Glenn Dryhurst
Pages 85-93
-
- Kejal Kantarci, Clifford R. Jack Jr.
Pages 95-105
-
-
Epilepsy
-
Front Matter
Pages 121-121
-
- Jun Natsume, Andrea Bernasconi, Mirko Diksic
Pages 123-129
-
- Bharathi Dasan Jagadeesan, Csaba Juhász, Diane C. Chugani, Harry T. Chugani
Pages 131-140
-
- Steven V. Pacia, Patricia A. Broderick
Pages 141-147
-
- Sonya Bahar, Minah Suh, Ashesh Mehta, Theodore H. Schwartz
Pages 149-175
-
-
- Imran I. Ali, Noor A. Pirzada
Pages 193-197
About this book
Bioimaging is in the forefront of medicine for the diagnosis and helps to predict the progression of AD via mild cognitive treatment of neurodegenerative disease. Conventional magnetic impairment (MCI) studies. resonance imaging (MRI) uses interactive external magnetic fields Novel neuroimaging technologies, such as neuromolecular and resonant frequencies of protons from water molecules. imaging (NMI) with a series of newly developed BRODERICK ® However, newer sequences, such as magnetization-prepared rapid PROBE sensors, directly image neurotransmitters, precursors, acquisition gradient echo (MPRAGE), are able to seek higher and metabolites in vivo, in real time and within seconds, at separate levels of anatomic resolution by allowing more rapid temporal and selective waveform potentials. NMI, which uses an imaging. Magnetic resonance spectroscopy (MRS) images electrochemical basis for detection, enables the differentiation of metabolic changes, enabling underlying pathophysiologic neurodegenerative diseases in patients who present with mesial dysfunction in neurodegeneration to be deciphered. Neuro- versus neocortical temporal lobe epilepsy. In fact, NMI has some 1 chemicals visible with proton H MRS include N-acetyl aspartate remarkable similarities to MRI insofar as there is technological (NAA), creatine/phosphocreatine (Cr), and choline (Cho); NAA dependence on electron and proton transfer, respectively, and is considered to act as an in vivo marker for neuronal loss and/or further dependence is seen in both NMI and MRI on tissue neuronal dysfunction. By extending imaging to the study of composition such as lipids.
Reviews
"The editors have succeeded in creating a bridge between the molecular biology of important neurodegenrative disorders and advances in brain imaging." - Journal of Neurosurgery
"...highly recommended to readers who require a solid review and reference text on the state of the art in bioimaging in neurodegenrative diseases." - Annals of Neurology
